Hypercholesterolemia promotes an osteoporotic phenotype

American Journal of Pathology

Volumn 181, Issue 3, 2012, Pages 928-936

  Pelton, Kristine ^a   Krieder, Jaclynn ^b   Joiner, Danese ^b   Freeman, Michael R ^a,c   Goldstein, Steven A ^b   Solomon, Keith R ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLIC ACID;

ANIMAL TISSUE; ARTICLE; BONE DENSITY; CHOLESTEROL DIET; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMUR; HYPERCHOLESTEROLEMIA; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; TRABECULAR BONE; VERTEBRA;

ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE RESORPTION; DIETARY FATS; FEMUR; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOPOROSIS; PHENOTYPE; SKULL; SPINE;

EID: 84865210268     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.05.034     Document Type: Article

References (63)

1. L.G. Raisz Clinical practice Screening for osteoporosis N Engl J Med 353 2005 164 171
2. T.D. Rachner, S. Khosla, L.C. Hofbauer Osteoporosis: now and the future Lancet 377 2011 1276 1287
3. S. Migliaccio, E.A. Greco, R. Fornari, L.M. Donini, A. Lenzi Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes 4 2011 273 282
4. Y. Yesil, Z. Ulger, M. Halil, B. Halacli, B.B. Yavuz, N.K. Yesil, M.E. Kuyumcu, M. Cankurtaran, S. Ariogul Coexistence of osteoporosis (OP) and coronary artery disease (CAD) in the elderly: it is not just a by chance event Arch Gerontol Geriatr 54 2011 473 476
5. J.R. Burnett, S.D. Vasikaran Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Ann Clin Biochem 39 2002 203 210
6. P.G. Masse, C.C. Tranchant, J. Dosy, S.M. Donovan Coexistence of osteoporosis and cardiovascular disease risk factors in apparently healthy, untreated postmenopausal women Int J Vitam Nutr Res 75 2005 97 106
7. S.I. McFarlane, R. Muniyappa, J.J. Shin, G. Bahtiyar, J.R. Sowers Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23 2004 1 10
8. J. Lidfeldt, L. Holmdahl, G. Samsioe, C. Nerbrand, P. Nyberg, B. Schersten, C.D. Agardh The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women's health in the Lund area study Metabolism 51 2002 267 270
9. D. von Muhlen, S. Safii, S.K. Jassal, J. Svartberg, E. Barrett-Connor Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study Osteoporos Int 18 2007 1337 1344
10. S. Yaturu, S. Humphrey, C. Landry, S.K. Jain Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes Med Sci Monit 15 2009 CR5 CR9
11. F.R. Maxfield, D. Wustner Intracellular cholesterol transport J Clin Invest 110 2002 891 898
12. R.E. Soccio, J.L. Breslow Intracellular cholesterol transport Arterioscler Thromb Vasc Biol 24 2004 1150 1160
13. L.W. Weber, M. Boll, A. Stampfl Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins World J Gastroenterol 10 2004 3081 3087
14. P.D. Broulik, J. Kapitola Interrelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women Endocr Regul 27 1993 57 60
15. P. Orozco Atherogenic lipid profile and elevated lipoprotein(a) are associated with lower bone mineral density in early postmenopausal overweight women Eur J Epidemiol 19 2004 1105 1112
16. F. Parhami Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 68 2003 373 378
17. F. Parhami, A. Garfinkel, L.L. Demer Role of lipids in osteoporosis Arterioscler Thromb Vasc Biol 20 2000 2346 2348
18. T. Yamaguchi, T. Sugimoto, S. Yano, M. Yamauchi, H. Sowa, Q. Chen, K. Chihara Plasma lipids and osteoporosis in postmenopausal women Endocr J 49 2002 211 217
19. V. Nuzzo, A.M. de Milita, T. Ferraro, A. Monaco, E. Florio, P. Miano, E. Montemarano, A. Zuccoli, F. de Terlizzi Analysis of skeletal status by quantitative ultrasonometry in a cohort of postmenopausal women with high blood cholesterol without documented osteoporosis Ultrasound Med Biol 35 2009 717 722
20. A. Tarakida, K. Iino, K. Abe, R. Taniguchi, T. Higuchi, H. Mizunuma, S. Nakaji Hypercholesterolemia accelerates bone loss in postmenopausal women Climacteric 14 2011 105 111
21. A. Poli, F. Bruschi, B. Cesana, M. Rossi, R. Paoletti, P.G. Crosignani Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women Obstet Gynecol 102 2003 922 926
22. J.P. Desager, Y. Horsmans Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors Clin Pharmacokinet 31 1996 348 371
23. C.R. Sirtori Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors Pharmacol Ther 60 1993 431 459
24. K.R. Solomon, M.R. Freeman Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19 2008 113 121
25. D.C. Bauer, G.R. Mundy, S.A. Jamal, D.M. Black, J.A. Cauley, F. Harris, T. Duong, S.R. Cummings Statin Use, Bone Mass and Fracture: An Analysis of Two Protective Studies M.K. Drezner, 1999 Blackwell Science, Inc. St. Louis, MO S179
26. T.M. Bocan Pleiotropic effects of HMG-CoA reductase inhibitors Curr Opin Investig Drugs 3 2002 1312 1317
27. K.A. Chan, S.E. Andrade, M. Boles, D.S. Buist, G.A. Chase, J.G. Donahue, M.J. Goodman, J.H. Gurwitz, A.Z. LaCroix, R. Platt Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women Lancet 355 2000 2185 2188
28. G. Lupattelli, A.M. Scarponi, G. Vaudo, D. Siepi, A.R. Roscini, F. Gemelli, M. Pirro, R.A. Latini, H. Sinzinger, S. Marchesi, E. Mannarino Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women Metabolism 53 2004 744 748
29. C.R. Meier, R.G. Schlienger, M.E. Kraenzlin, B. Schlegel, H. Jick HMG-CoA reductase inhibitors and the risk of fractures [see comments] JAMA 283 2000 3205 3210
30. G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, G. Gutierrez Stimulation of bone formation in vitro and in rodents by statins Science 286 1999 1946 1949
31. G.R. Mundy Statins and their potential for osteoporosis Bone 29 2001 495 497
32. M.J. Rogers Statins: lower lipids and better bones? Nat Med 6 2000 21 23
33. M.W. Schoofs, M.C. Sturkenboom, M. van der Klift, A. Hofman, H.A. Pols, B.H. Stricker HMG-CoA reductase inhibitors and the risk of vertebral fracture J Bone Miner Res 19 2004 1525 1530
34. A. Waldman, L. Kritharides The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia Drugs 63 2003 139 152
35. P.S. Wang, D.H. Solomon, H. Mogun, J. Avorn HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients [see comments] JAMA 283 2000 3211 3216
36. N. Werner, G. Nickenig, U. Laufs Pleiotropic effects of HMG-CoA reductase inhibitors Basic Res Cardiol 97 2002 105 116
37. J.F. Whitfield Statins: new drugs for treating osteoporosis? Expert Opin Investig Drugs 10 2001 409 415
38. L.N. Bakhireva, M.R. Shainline, S. Carter, S. Robinson, S.J. Beaton, J.J. Nawarskas, M.J. Gunter Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women Pharmacotherapy 30 2010 879 887
39. A.C. Cruz, B.L. Gruber Statins and osteoporosis: can these lipid-lowering drugs also bolster bones? Cleve Clin J Med 69 2002 277 278 280282, 287288
40. T.M. Bocan, E. Ferguson, W. McNally, P.D. Uhlendorf, S. Bak Mueller, P. Dehart, D.R. Sliskovic, B.D. Roth, B.R. Krause, R.S. Newton Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor: CI-981: comparison with selected HMG-CoA reductase inhibitors Biochim Biophys Acta 1123 1992 133 144
41. A. Corsini, F.M. Maggi, A.L. Catapano Pharmacology of competitive inhibitors of HMG-CoA reductase Pharmacol Res 31 1995 9 27
42. D.E. Duggan, I.W. Chen, W.F. Bayne, R.A. Halpin, C.A. Duncan, M.S. Schwartz, R.J. Stubbs, S. Vickers The physiological disposition of lovastatin Drug Metab Dispos 17 1989 166 173
43. J.I. Germershausen, V.M. Hunt, R.G. Bostedor, P.J. Bailey, J.D. Karkas, A.W. Alberts Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo Biochem Biophys Res Commun 158 1989 667 675
44. R.J. Gerson, J.S. MacDonald, A.W. Alberts, D.J. Kornbrust, J.A. Majka, R.J. Stubbs, D.L. Bokelman Animal safety and toxicology of simvastatin and related hydroxy- methylglutaryl-coenzyme A reductase inhibitors Am J Med 87 1989 28S 38S
45. T. Koga, Y. Shimada, M. Kuroda, Y. Tsujita, K. Hasegawa, M. Yamazaki Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Biochim Biophys Acta 1045 1990 115 120
46. T. Komai, K. Kawai, T. Tokui, Y. Tokui, C. Kuroiwa, E. Shigehara, M. Tanaka Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys Eur J Drug Metab Pharmacokinet 17 1992 103 113
47. R.A. Parker, R.W. Clark, S.Y. Sit, T.L. Lanier, R.A. Grosso, J.J. Wright Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors J Lipid Res 31 1990 1271 1282
48. F.L. Tse, H.T. Smith, F.H. Ballard, J. Nicoletti Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey Biopharm Drug Dispos 11 1990 519 531
49. S. Vickers, C.A. Duncan, I.W. Chen, A. Rosegay, D.E. Duggan Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug Drug Metab Dispos 18 1990 138 145
50. C.M. White A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin J Clin Pharmacol 42 2002 963 970
51. F. Parhami, Y. Tintut, W.G. Beamer, N. Gharavi, W. Goodman, L.L. Demer Atherogenic high-fat diet reduces bone mineralization in mice J Bone Miner Res 16 2001 182 188
52. You L, Sheng ZY, Tang CL, Chen L, Pan L, Chen JY: High cholesterol diet increases osteoporosis risk via inhibiting bone formation in rats. Acta Pharmacol Sin 32:14981504
53. K.R. Solomon, K. Pelton, K. Boucher, J. Joo, C. Tully, D. Zurakowski, C.P. Schaffner, J. Kim, M.R. Freeman Ezetimibe is an inhibitor of tumor angiogenesis Am J Pathol 174 2009 1017 1026
54. The Jackson Laboratory Densitometric survey of 11 inbred strains of mice. MPD:224, Jaxpheno1 Mouse Phenome Database 2006
55. W.G. Beamer, L.R. Donahue, C.J. Rosen, D.J. Baylink Genetic variability in adult bone density among inbred strains of mice Bone 18 1996 397 403
56. J.E. Wergedal, M.H. Sheng, C.L. Ackert-Bicknell, W.G. Beamer, D.J. Baylink Genetic variation in femur extrinsic strength in 29 different inbred strains of mice is dependent on variations in femur cross-sectional geometry and bone density Bone 36 2005 111 122
57. N. Ishimori, R. Li, K.A. Walsh, R. Korstanje, J.A. Rollins, P. Petkov, M.T. Pletcher, T. Wiltshire, L.R. Donahue, C.J. Rosen, W.G. Beamer, G.A. Churchill, B. Paigen Quantitative trait loci that determine BMD in C57BL/6J and 129S1/SvImJ inbred mice J Bone Miner Res 21 2006 105 112
58. G.R. Mundy Osteoporosis and inflammation Nutr Rev 65 2007 S147 S151
59. K.R. Solomon, L.D. Adolphson, D.A. Wank, K.P. McHugh, P.V. Hauschka Caveolae in human and murine osteoblasts J Bone Miner Res 15 2000 2391 2401
60. K.R. Solomon, T.E. Danciu, L.D. Adolphson, L.E. Hecht, P.V. Hauschka Caveolin-enriched membrane signaling complexes in human and murine osteoblasts J Bone Miner Res 15 2000 2380 2390
61. E.J. Samelson, L.A. Cupples, M.T. Hannan, P.W. Wilson, S.A. Williams, V. Vaccarino, Y. Zhang, D.P. Kiel Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study Bone 34 2004 557 561
62. L.Y. Wu, T.C. Yang, S.W. Kuo, C.F. Hsiao, Y.J. Hung, C.H. Hsieh, H.C. Tseng, A.T. Hsieh, T.W. Chen, J.B. Chang, D. Pei Correlation between bone mineral density and plasma lipids in Taiwan Endocr Res 29 2003 317 325
63. A.H. Lichtman, S.K. Clinton, K. Iiyama, P.W. Connelly, P. Libby, M.I. Cybulsky Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate Arterioscler Thromb Vasc Biol 19 1999 1938 1944